东航物流“东东测”赋能航空冷链 硬核科技驱动生物制品运输再破局

Core Viewpoint - The successful transportation of high-value biological products from Lanzhou to Changchun using Eastern Airlines' cold chain logistics technology highlights the critical role of advanced temperature control solutions in the biopharmaceutical industry, addressing key logistical challenges and enhancing product viability in global markets [1][3]. Group 1: Technology and Innovation - The "Dongdong Measurement" device developed by Eastern Airlines Logistics integrates precise sensing, safety protection, and compliance tracking, overcoming industry challenges related to temperature control during air transport [1][2]. - This device maintains temperature measurement accuracy within ±0.5°C, aligning with the stringent requirements for biological products, and meets international pharmaceutical cold chain standards [2]. - The device employs encrypted storage and blockchain technology for real-time temperature data recording and compliance with domestic and international regulations, ensuring traceability for up to five years [2]. Group 2: Logistics Efficiency - The transportation time for biological products from Lanzhou to Changchun has been significantly reduced from 2-3 days via road cold chain to just 6-8 hours through air logistics, enhancing the preservation of product viability [3]. - The comprehensive service system established by Eastern Airlines Logistics includes equipment development, compliance certification, route assurance, and data traceability, maximizing the efficiency of air logistics [3]. Group 3: Industry Impact - The application of "Dongdong Measurement" not only improves transportation efficiency but also provides a replicable and scalable cold chain solution for high-value products, facilitating better integration of Gansu's biopharmaceutical enterprises into domestic and international markets [3][4]. - The support from national policies for high-end pharmaceutical air cold chain logistics underscores the importance of air logistics as a foundational infrastructure for the globalization of the pharmaceutical industry [3].